Johnson & Johnson

Johnson & Johnson Equity

The The Equity of Johnson & Johnson (JNJ) as of Oct 20, 2026 is 81.54 B USD. In the previous year, The Equity was 71.49 B USD — a change of 14.06% (higher).

Equity

81.54 BUSD

YoY

14.06%

Last updated:

In 2025, Johnson & Johnson's equity was 81.54 B USD, a 14.06% increase from the 71.49 B USD equity in the previous year.

The Johnson & Johnson Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
59.75 B USD
Jan 1, 2019
59.47 B USD
Jan 1, 2020
63.28 B USD
Jan 1, 2021
74.02 B USD
Jan 1, 2022
76.80 B USD
Jan 1, 2023
68.77 B USD
Jan 1, 2024
71.49 B USD
Jan 1, 2025
81.54 B USD
The Johnson & Johnson Equity history
YEAREquityYoY
81.54 BUSD+14.06%
71.49 BUSD+3.95%
68.77 BUSD-10.46%
76.80 BUSD+3.76%
74.02 BUSD+16.98%
63.28 BUSD+6.40%
59.47 BUSD-0.47%
59.75 BUSD-0.68%
60.16 BUSD-14.57%
70.42 BUSD-1.03%
71.15 BUSD+2.00%
69.75 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Johnson & Johnson Stock analysis

What does Johnson & Johnson do? Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Johnson & Johnson's Equity

Johnson & Johnson's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Johnson & Johnson's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Johnson & Johnson's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Johnson & Johnson's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Johnson & Johnson’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Johnson & Johnson stock

The Equity of Johnson & Johnson is 81.54 B USD in 2025.

The Equity of Johnson & Johnson changed from 71.49 B USD to 81.54 B USD, representing a 14.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Johnson & Johnson since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Johnson & Johnson historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Johnson & Johnson

All Key Metrics — Johnson & Johnson